基本信息
views: 1
Career Trajectory
Bio
Wael Alanazi earned his Bachelor’s degree in Pharmaceutical Sciences from King Saud University in 2011. After graduation, Wael worked for the Drug Sector at Saudi Food and Drug Authority (SFDA) for evaluation of the quality of pharmaceutical products. In 2012, he worked as a teaching assistant in Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University. In 2013, Wael started his doctoral research in Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, USA. He joined Dr. Jackson’s laboratory and completed his thesis in title “The role of recurrent insulin-induced hypoglycemia on renal prostanoids production, (pro)renin receptor expression and oxidative stress in heart and kidney”. In 2016, Wael earned his Ph.D. in Pharmacology and published several peer-reviewed articles. In 2017, Dr. Wael joined Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University as an assistant professor, and was promoted to associate professor in 2021.
RESEARCH INTERESTS:
• Identify novel therapeutic strategies for prevention of diabetes-induced renal and cardiovascular diseases in various animal models of diabetes.
• Investigate the roles of renin angiotensin system, cyclooxygenases and oxidative stress in diabetic complications.
• Finding the link between blood glucose levels and different vicious pathways causing kidney damage and hypertension in hypoglycemic and/or hyperglycemic animal models.
• Study the antidiabetic activities of new synthetic compounds, and their mechanism of action in glycemic control.
Research Interests
Papers共 56 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
SAUDI PHARMACEUTICAL JOURNALno. 3 (2024): 101964-101964
Saudi Pharmaceutical Journalno. 7 (2023): 1351-1359
Wael A. A. Alanazi, Abdulrahman S. S. Alanazi,Doaa M. M. El-Nagar, Abdullah M. M. Aljuraybah,Sary Alsanea,Metab Alharbi
PHARMACEUTICALSno. 2 (2023): 295-295
Toxicsno. 6 (2023): 546-546
Saudi Pharmaceutical Journalno. 3 (2023): 370-381
Pharmaceuticsno. 6 (2023): 1683-1683
Biomedicinesno. 10 (2023): 2674-2674
Load More
Author Statistics
#Papers: 58
#Citation: 785
H-Index: 13
G-Index: 27
Sociability: 5
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn